iShares MSCI South Korea ETF vs Vital Farms Inc — how do they compare? iShares MSCI South Korea ETF trades at $164.33, while Vital Farms Inc trades at $13.23 (market cap $581.88M). The key difference: iShares MSCI South Korea ETF is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals.
| EWY | VITL | |
|---|---|---|
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $219.20 | $52.41 |
52-Week Low | $70.65 | $8.28 |
Market Cap | — | $581.88M |
Enterprise Value | — | $584.69M |
Signals from Pluang's Aura AI — not financial advice
EWY is trading at $163.67, down 7.52% with significant volatility driven by its heavy concentration in South Korean semiconductor giants Samsung and SK Hynix. The ETF has entered bear market territory, reflecting global tech sector pressures and foreign investor selling. Technical indicators show bearish momentum with RSI near oversold levels at 28, while support sits at $157. Recent news highlights the Kospi Index's 21% decline from YTD highs, creating both risk and potential opportunity.
The outlook remains challenged by semiconductor cycle volatility and concentrated exposure, but long-term AI demand fundamentals provide potential upside. Key risks include single-stock concentration, foreign capital flows, and global tech sentiment shifts. Investors should weigh near-term volatility against structural semiconductor growth drivers.
Vital Farms (VITL) trades at $13.53, up 3.2% with a bullish technical signal from moving averages and oscillators. The company shows solid fundamentals with a P/E of 13.06, P/S of 0.79, and strong profitability metrics including 35.21% gross margin and 15.44% ROE. Recent quarterly earnings have been mixed with one beat and two misses, while analyst consensus remains positive with 56% buy ratings and a $13.50 price target. However, negative net cash flow and a pending class action lawsuit present notable concerns.
The outlook balances attractive valuation against execution risks. The stock's below-market P/S ratio and strong profitability provide fundamental support, but recent earnings misses, declining projected net income for 2026, and legal uncertainties create headwinds. The bullish technical setup and analyst support suggest potential upside, though investors must weigh these against the company's cash flow challenges and competitive pressures in the natural foods sector.
Trailing returns across standard periods
Latest headlines on both assets
EWY tracks the MSCI Korea 25/50 Index, offering targeted exposure to large and mid-cap companies in South Korea. It is structurally centered on the global technology supply chain, industrials, and financial services, serving as a liquid tool for investors seeking a single-country view of this advanced, innovation-led economy.
Read more on EWY →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →